Myomo (MYO) EBT Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,150.00 |
| Jun 30, 2025 | -1,260.00 |
| Mar 31, 2025 | -8,895.00 |
| Dec 31, 2024 | 6,467.00 |
| Sep 30, 2024 | 383.00 |
| Jun 30, 2024 | 8,658.00 |
| Mar 31, 2024 | -23,301.00 |
| Dec 31, 2023 | 17,206.00 |
| Sep 30, 2023 | -2,195.00 |
| Jun 30, 2023 | 5,841.00 |
| Mar 31, 2023 | -1,681.00 |
| Dec 31, 2022 | 1,204.00 |
| Sep 30, 2022 | 855.00 |
| Jun 30, 2022 | -847.00 |
| Mar 31, 2022 | 168.00 |
| Dec 31, 2021 | -2,608.00 |
| Sep 30, 2021 | 3,753.00 |
| Jun 30, 2021 | 4,157.00 |
| Mar 31, 2021 | -38,544.00 |
| Dec 31, 2020 | 40,398.00 |
| Sep 30, 2020 | 23,865.00 |
| Jun 30, 2020 | -564.00 |
| Mar 31, 2020 | -21,430.00 |
| Dec 31, 2019 | 29,685.00 |
| Sep 30, 2019 | -16,822.00 |
| Jun 30, 2019 | 2,160.00 |
| Mar 31, 2019 | 2,961.00 |
| Dec 31, 2018 | 9,470.00 |
| Sep 30, 2018 | -2,106.00 |
| Jun 30, 2018 | 33,754.00 |
| Mar 31, 2018 | 158,709.00 |
| Dec 31, 2017 | -203,828.00 |
| Sep 30, 2017 | 37,552.00 |
| Jun 30, 2017 | 760,055.00 |
| Mar 31, 2017 | -790,671.00 |
| Dec 31, 2016 | 8,917.00 |
| Sep 30, 2016 | -21,819.00 |